Host miRNAs as biomarkers of SARS-CoV-2 infection: a critical review
Kato Pollet, Nathalie Garnier, Sabine Szunerits, Annemieke Madder, Didier Hober, Ilka Engelmann
Abstract
SARS-CoV-2 infection leads to miRNA expression changes in body fluids of COVID-19 patients. This review summarizes data on miRNAs that change expression during COVID-19 and can potentially be used as biomarkers for COVID-19 and/or disease severity.
Topics & Concepts
microRNACoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakBiomarkerSars virusDiseaseBiologyMedicineVirologyComputational biologyInfectious disease (medical specialty)PathologyGeneticsGeneOutbreakMicroRNA in disease regulationExtracellular vesicles in diseaseCircular RNAs in diseases